(OP: CBIH )

0.0006 -0.0001 (-14.29%)

Streaming Delayed Price Updated: 1:20 PM EDT, Oct 31, 2024 Add to My Watchlist

Price and Volume

Volume	14,000
Open	0.0006
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0007
Today's Range	0.0006 - 0.0006
52wk Range	0.0004 - 0.0020
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine

July 08, 2024

Houston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience International Holdings (OTC Pink:...

Via Newsfile

Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions

July 01, 2024

As rates of pancreatic and breast cancer increase among the population, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) opted to address the infamous trend with new treatment methodologies....

Via Benzinga

Performance

YTD	-25.00%	-25.00%
1 Month	-14.29%	-14.29%
3 Month	-25.00%	-25.00%
6 Month	-25.00%	-25.00%
1 Year	N/A	N/A

More News

CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments

July 01, 2024

Via Newsfile

CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader

June 24, 2024

Via Newsfile

Texas Cannabis Company Secures $2B Valuation From LA Financial Firm

June 17, 2024

Via Benzinga

CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment

June 17, 2024

Via Newsfile

Vita Biotech Retains CBIH Services for Clinical Studies

June 05, 2024

Via Newsfile

Executive Changes In Marijuana Industry You Should Know About, New Cannabis Appointments & More

June 03, 2024

Via Benzinga

Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation

May 29, 2024

Via Newsfile

CBIH Engages Prestigious Law Firm for its First Patent Applications

May 20, 2024

Via Newsfile

CBIH Welcomes New Treasurer and Director, Mr. John E. Jones

May 06, 2024

Via Newsfile

Who's Who In Cannabis: Latest Executive Changes You Should Know About

April 15, 2024

Via Benzinga

CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"

March 20, 2024

Via Newsfile

CBIH Announces the Retirement of One Billion Shares

March 06, 2024

Via Newsfile

Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member

February 26, 2024

Via Newsfile

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm

February 20, 2024

Via Newsfile

A Letter From Cannabis Bioscience International Holdings CEO Dante Picazo Regarding Actual Progress and Plans for 2024

December 18, 2023

Via Newsfile

SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials

December 15, 2023

Via Benzinga

Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings

December 15, 2023

Via Newsfile

Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement

December 06, 2023

Via NewMediaWire

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website

September 11, 2023

Via NewMediaWire

FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH

August 21, 2023

Via NewMediaWire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.